Juan Tao

Upcoming novel treatments for hidradenitis suppurativa: An overview of the pipeline

Abstract Recent developments in hidradenitis suppurativa (HS) have focused on targeting key inflammatory pathways implicated in the pathogenesis of the disease, including interleukin (IL)‐17, IL‐1, tumour necrosis factor (TNF), Janus kinase (JAK) and tyrosine kinase 2 (TYK2) sign...

Efficacy evaluation of flap repair after radical excision for axillary hidradenitis suppurativa

The data that support the findings of this study are available from the corresponding author upon reasonable request.